Ml. Veigl et al., BIALLELIC INACTIVATION OF HMLH1 BY EPIGENETIC GENE SILENCING, A NOVELMECHANISM CAUSING HUMAN MSI CANCERS, Proceedings of the National Academy of Sciences of the United Statesof America, 95(15), 1998, pp. 8698-8702
Mutations of DNA mismatch repair genes, including the hMLH1 gene, have
been linked to human colon and other cancers in which defective DNA r
epair is evidenced by the associated instability of DNA microsatellite
sequences (MSI). Germ-line hMLH1 mutations are causally associated wi
th inherited MSI colon cancer, and somatic mutations are causally asso
ciated with sporadic MSI colon cancer. Previously however, we demonstr
ated that in many sporadic MSI colon cancers hMLH1 and all other DNA m
ismatch repair genes are wild type. To investigate this class of tumor
s further, we examined a group of MSI cancer cell lines, most of which
were documented as established from antecedent MSI-positive malignant
tumors. In five of six such cases we found that hMLH1 protein was abs
ent, even though hMLH1-coding sequences were wild type. In each such c
ase, absence of hMLH1 protein was associated with the methylation of t
he hMLH1 gene promoter. Furthermore, in each case, treatment with the
demethylating agent 5-azacytidine induced expression of the absent hML
H1 protein. Moreover, in single cell clones, hMLH1 expression could be
turned on, off, and on again by 5-azacytidine exposure, washout, and
reexposure. This epigenetic inactivation of hMLH1 additionally account
ed for the silencing of both maternal and paternal tumor hMLH1 alleles
, both of which could be reactivated by 5-azacytidine. In summary, sub
stantial numbers of human MSI cancers appear to arise by hMLH1 silenci
ng via an epigenetic mechanism that can inactivate both of the hMLH1 a
lleles. Promoter methylation is intimately associated with this epigen
etic silencing mechanism.